Cite
Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay
MLA
Jun-Hee Lee, et al. “Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay.” Journal of Breast Cancer, Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....dae93308a6c224d540cbef790289a212&authtype=sso&custid=ns315887.
APA
Jun-Hee Lee, Jai Min Ryu, Jee Hyun Ahn, Soo Youn Cho, Se Kyung Lee, Jonghan Yu, Byung Joo Chae, Seok Jin Nam, Jinil Han, Jeong Eon Lee, & Seok Won Kim. (2022). Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay. Journal of Breast Cancer.
Chicago
Jun-Hee Lee, Jai Min Ryu, Jee Hyun Ahn, Soo Youn Cho, Se Kyung Lee, Jonghan Yu, Byung Joo Chae, et al. 2022. “Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay.” Journal of Breast Cancer, January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....dae93308a6c224d540cbef790289a212&authtype=sso&custid=ns315887.